183 related articles for article (PubMed ID: 31798209)
1. Thermal Ablation of T1a Renal Cell Carcinoma: The Clinical Evidence.
Young S; Golzarian J; Anderson JK
Semin Intervent Radiol; 2019 Dec; 36(5):367-373. PubMed ID: 31798209
[TBL] [Abstract][Full Text] [Related]
2. Trends in Percutaneous Thermal Ablation Therapies in the Treatment of T1a Renal Cell Carcinomas Rather than Partial Nephrectomy/Radical Nephrectomy.
Shakeri S; Raman SS
Semin Intervent Radiol; 2019 Aug; 36(3):183-193. PubMed ID: 31435126
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous Thermal Ablation for Treatment of T1a Renal Cell Carcinomas.
Shakeri S; Raman SS
Radiol Clin North Am; 2020 Sep; 58(5):981-993. PubMed ID: 32792128
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous Image-guided Thermal Ablation for Renal Cell Carcinoma.
Fujimori M; Yamanaka T; Sugino Y; Matsushita N; Sakuma H
Interv Radiol (Higashimatsuyama); 2020 Jun; 5(2):32-42. PubMed ID: 36284654
[TBL] [Abstract][Full Text] [Related]
5. Modern Management of Localized Renal Cell Carcinoma- Is Ablation Part of the Equation?
Leopold Z; Passarelli R; Mikhail M; Tabakin A; Chua K; Ennis RD; Nosher J; Singer EA
J Kidney Cancer VHL; 2022; 9(3):5-23. PubMed ID: 36060450
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
[TBL] [Abstract][Full Text] [Related]
8. Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease-A National Register Study.
Almdalal T; Sundqvist P; Harmenberg U; Hellström M; Lindskog M; Lindblad P; Lundstam S; Ljungberg B
Eur Urol Open Sci; 2022 May; 39():22-28. PubMed ID: 35528783
[TBL] [Abstract][Full Text] [Related]
9. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
[TBL] [Abstract][Full Text] [Related]
10. Comparative Outcome of Computed Tomography-guided Percutaneous Radiofrequency Ablation, Partial Nephrectomy or Radical Nephrectomy in the Treatment of Stage T1 Renal Cell Carcinoma.
Cooper CJ; Teleb M; Dwivedi A; Rangel G; Sanchez LA; Laks S; Akle N; Nahleh Z
Rare Tumors; 2015 Feb; 7(1):5583. PubMed ID: 25918603
[TBL] [Abstract][Full Text] [Related]
11. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
Uhlig A; Uhlig J; Trojan L; Kim HS
J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
[TBL] [Abstract][Full Text] [Related]
13. Can ablation win against partial nephrectomy and become first line therapy in cT1a renal tumours?
Sandbergen L; Guven S; Laguna MP
Curr Opin Urol; 2019 Jan; 29(1):70-77. PubMed ID: 30308573
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous microwave ablation therapy of renal cancer local relapse after radical nephrectomy: a feasibility and efficacy study.
Ierardi AM; Carnevale A; Rossi UG; Renzulli M; Garanzini E; Golfieri R; Macchione N; Cittanti C; Giganti M; Carrafiello G
Med Oncol; 2020 Mar; 37(4):27. PubMed ID: 32166412
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous ablation of the small renal mass-techniques and outcomes.
Gunn AJ; Gervais DA
Semin Intervent Radiol; 2014 Mar; 31(1):33-41. PubMed ID: 24596438
[TBL] [Abstract][Full Text] [Related]
16. Treatment of localised renal cell carcinoma.
Van Poppel H; Becker F; Cadeddu JA; Gill IS; Janetschek G; Jewett MA; Laguna MP; Marberger M; Montorsi F; Polascik TJ; Ukimura O; Zhu G
Eur Urol; 2011 Oct; 60(4):662-72. PubMed ID: 21726933
[TBL] [Abstract][Full Text] [Related]
17. Use of surveillance imaging following treatment of small renal masses.
Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous Microwave Ablation versus Laparoscopic Partial Nephrectomy for cT1a Renal Cell Carcinoma: A Propensity-matched Cohort Study of 1955 Patients.
Yu J; Zhang X; Liu H; Zhang R; Yu X; Cheng Z; Han Z; Liu F; Hao G; Mu MJ; Liang P
Radiology; 2020 Mar; 294(3):698-706. PubMed ID: 31961239
[TBL] [Abstract][Full Text] [Related]
19. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
